Angiotensin II (Ang II) plays a key role in the regulation of blood pressure and fluid homeostasis. Valsartan is a highly selective Ang II receptor blocker that specifically and selectively blocks Ang II at the AT1-receptor. In animal models, valsartan has shown positive effects on vasoconstriction, proliferation, remodelling, endothelial function and thrombogenesis, inflammation and atherosclerosis. These data are likely to be confirmed by the results of current clinical trials and valsartan is set to provide improved cardiovascular therapy in the future.
PoolJ, OparilS, HednerTDose-responsive antihypertensive efficacy of valsartan, a new angiotensin II-receptor blocker.Clin Ther1998; 20: 1106–14.
2.
ShettySS, DelGrandeD.Differential inhibition of the pre-junctional actions of angiotensin II in rat atria by valsartan, irbesartan, eprosartan, and losartan.J Pharmacol Ext Ther2000; 294: 179–86.
3.
TongCF, YingWY, HuaRYEffect of valsartan and cap-topril in rabbit carotid injury: possible involvement of bradykinin in the antiproliferative action of the renin-angiotensin blockade.JRAAS (in press).
4.
PrescottMF, WebbRL, ReidyMA.Angiotensin converting enzyme inhibition versus angiotensin II AT1 receptor antagonist.Amer J Pathol1991; 139: 1291–6.
5.
LedinghamJM, LavertyR.Remodelling of resistance arteries in genetically hypertensive rats by treatment with valsartan, an angiotensin II receptor antagonist.Clin Exp Pharmacol Physiol1996; 23: 576–8.
6.
LogingJA, NewRB, BaicuSCEffects of angiotensin type-I receptor blockade on pericardial fibrosis.J Surg Res1999; 87: 101–7.
7.
SironiL, CalvioAM, ArnaboldiLEffect of valsartan, an AT1-receptor antagonist, on angiotensin II-induced PAI-1 biosynthesis in smooth muscle cells.Hypertension (in press).
8.
De La HerasN, Vazques-PérezS, Navarro-CidJAngiotensin II type 1 receptor antagonism prevented the effects of hypercholesterolemia on plasma fibrinolytic balance in rabbits. High Blood Pressure Council, Washington October 2000.Hypertension2000; 36: 694(abstract).
9.
MervaalaEM, MullerDN, ParkJKMonocyte infiltration and adhesion molecules in a rat model of high human renin hypertension.Hypertension1999; 33: 389–95.
10.
HilgersKF, HartnerA, PorstMMonocyte chemoat-tractant protein-1 and macrophage infiltration in hypertensive kidney injury: role of the angiotensin II type 1 receptor.Kidney Int2000; 58: 2408–19.
11.
de las HerasN, AragoncilloP, MaesoRAT(1) receptor antagonism reduces endothelial dysfunction and intimal thickening in atherosclerotic rabbits.Hypertension1999; 34: 969–75.
12.
ScheideggerKJ, ButlerS, WitztumJL.Angiotensin II increases macrophage-mediated modification of low-density lipoprotein via a lipoxygenase-dependent pathway.J Biol Chem1997; 272: 21609–15.
13.
de GasparoM, HessP, Nuesslein-HildesheimBCombination of non-hypotensive doses of valsartan and enalapril improves survival of spontaneously hypertensive rats with endothelial dysfunction.JRAAS2000; 1; 151–8.
